{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Discrete&page=51", "query": { "intervention": "Discrete", "page": 51 }, "page_size": 10 }, "pagination": { "page": 51, "page_size": 10, "total_count": 2006, "total_pages": 201, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Discrete&page=52&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Discrete&page=50&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-05T21:04:31.984Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03298061", "title": "Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Churg-Strauss Syndrome", "Eosinophilic Granulomatosis With Polyangiitis" ], "interventions": [ { "name": "Mepolizumab", "type": "DRUG" }, { "name": "Prednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2015-04-14", "completion_date": "2023-02-16", "has_results": true, "last_update_posted_date": "2024-03-12", "last_synced_at": "2026-11-05T21:04:31.984Z", "location_count": 14, "location_summary": "Denver, Colorado • Bethesda, Maryland • Boston, Massachusetts + 10 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03298061" }, { "nct_id": "NCT03125291", "title": "Optimizing a Drug Abuse Prevention Program for Dissemination", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Substance Abuse", "Mental Health", "Educational Problems" ], "interventions": [ { "name": "Bridges 4-week Program", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Arizona State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "15 Years", "sex": "ALL", "summary": "10 Years to 15 Years" }, "enrollment_count": 664, "start_date": "2015-07-28", "completion_date": "2019-09", "has_results": false, "last_update_posted_date": "2018-07-05", "last_synced_at": "2026-11-05T21:04:31.984Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT03125291" }, { "nct_id": "NCT01523613", "title": "High-strength Glass-ionomer Dental Restorations", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dental Caries" ], "interventions": [ { "name": "Chemfil ROCK Glassionomer restoration", "type": "DEVICE" }, { "name": "Fuji IX GP Extra Glassionomer restoration", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Mathilde Peters, DMD, PhD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "16 Years", "sex": "ALL", "summary": "7 Years to 16 Years" }, "enrollment_count": 93, "start_date": "2011-11", "completion_date": "2014-10", "has_results": true, "last_update_posted_date": "2017-10-03", "last_synced_at": "2026-11-05T21:04:31.984Z", "location_count": 1, "location_summary": "Flint, Michigan", "locations": [ { "city": "Flint", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01523613" }, { "nct_id": "NCT04701645", "title": "Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Ovarian Cancer", "Fallopian Tube Cancer", "Peritoneal Cancer", "Ovarian Cancer Stage III", "Ovarian Cancer Stage IV", "Fallopian Tube Cancer Stage IV", "Fallopian Tube Cancer Stage III" ], "interventions": [ { "name": "Microdevice", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 20, "start_date": "2022-11-01", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-05-18", "last_synced_at": "2026-11-05T21:04:31.984Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04701645" }, { "nct_id": "NCT06733675", "title": "Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteer", "Pharmacokinetics", "Safety", "Drug-Drug Interaction (DDI)", "FDC" ], "interventions": [ { "name": "Ledaborbactam etzadroxil", "type": "DRUG" }, { "name": "Ceftibuten", "type": "DRUG" }, { "name": "Ceftibuten-ledaborbactam etzadroxil", "type": "DRUG" }, { "name": "Esomeprazole", "type": "DRUG" }, { "name": "amoxicillin-clavulanate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Basilea Pharmaceutica", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 96, "start_date": "2025-01-07", "completion_date": "2026-12-30", "has_results": false, "last_update_posted_date": "2026-11-05", "last_synced_at": "2026-11-05T21:04:31.984Z", "location_count": 1, "location_summary": "Lenexa, Kansas", "locations": [ { "city": "Lenexa", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06733675" }, { "nct_id": "NCT05701657", "title": "Nutrition for Precision Health, Powered by the All of Us", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Nutrition", "Health", "Dietary Habits" ], "interventions": [ { "name": "Diet A", "type": "OTHER" }, { "name": "Diet B", "type": "OTHER" }, { "name": "Diet C", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "RTI International", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 8000, "start_date": "2023-04-14", "completion_date": "2027-02-25", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-11-05T21:04:31.984Z", "location_count": 14, "location_summary": "Birmingham, Alabama • Davis, California • Los Angeles, California + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Davis", "state": "California" }, { "city": "Davis", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "West Hollywood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05701657" }, { "nct_id": "NCT01584609", "title": "A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acute Ischemic Stroke From Large Vessel Occlusion" ], "interventions": [ { "name": "Penumbra System with Separator 3D", "type": "DEVICE" }, { "name": "Penumbra System alone", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Penumbra Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 198, "start_date": "2012-04", "completion_date": "2017-12", "has_results": true, "last_update_posted_date": "2018-09-13", "last_synced_at": "2026-11-05T21:04:31.984Z", "location_count": 8, "location_summary": "Newport Beach, California • Denver, Colorado • Hartford, Connecticut + 5 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Saint Paul", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01584609" }, { "nct_id": "NCT06436209", "title": "Cognitive Control & the Functional Organization of the Frontal Cortex", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Multitasking Behavior and Neural Representations Associated With Multitasking Ability", "Healthy Volunteers", "Executive Function" ], "interventions": [ { "name": "Multitask Practice Intervention (MPI)", "type": "BEHAVIORAL" }, { "name": "Single-task Practice Intervention (SPI)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Brown University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 60, "start_date": "2024-03-27", "completion_date": "2026-07-31", "has_results": false, "last_update_posted_date": "2025-08-15", "last_synced_at": "2026-11-05T21:04:31.984Z", "location_count": 1, "location_summary": "Providence, Rhode Island", "locations": [ { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT06436209" }, { "nct_id": "NCT06390930", "title": "Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Multiple Sclerosis", "Multiple Sclerosis, Relapsing-Remitting", "Multiple Sclerosis, Secondary Progressive" ], "interventions": [ { "name": "Acute Intermittent Hypoxia", "type": "OTHER" }, { "name": "Sham Acute Intermittent Hypoxia", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Shirley Ryan AbilityLab", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 22, "start_date": "2025-02-01", "completion_date": "2027-07", "has_results": false, "last_update_posted_date": "2026-02-23", "last_synced_at": "2026-11-05T21:04:31.984Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06390930" }, { "nct_id": "NCT02043405", "title": "Weight Loss and/or Exercise Training to Discover Muscle Lipids Related to Insulin Sensitivity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes", "Pre-diabetes" ], "interventions": [ { "name": "Weight loss and exercise training intervention", "type": "BEHAVIORAL" }, { "name": "Weight loss Only Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "30 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "30 Years to 60 Years" }, "enrollment_count": 21, "start_date": "2014-01", "completion_date": "2015-08-03", "has_results": false, "last_update_posted_date": "2022-04-25", "last_synced_at": "2026-11-05T21:04:31.984Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02043405" } ] }